Optional product analytics
With your permission, we use privacy-limited analytics to understand which research journeys work. We do not run advertising trackers or session replay. You can change this choice in Preferences. Read the Privacy Policy.
Synopsys Inc.'s published Reduce conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $86.4B | |
|---|---|---|
| Revenue (ttm) | 9.4B | |
| Net income (ttm) | 1.1B | |
| EPS (ttm) | $5.64 | |
| Shares out | 191.6M | |
| P/E (trailing) | 85.4x | |
| P/E (forward) | 23.3x | |
| Volume | 1,607,943 | |
| Beta | 1.21 |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | 2025-10-31 | Trend |
| Revenue | $4.20B | $4.62B | $5.32B | $6.13B | $7.05B | +13.8% |
| Gross profit | $3.34B | $3.72B | $4.29B | $4.88B | $5.43B | +12.9% |
| Operating income | $734.8M | $1.15B | $1.27B | $1.36B | $914.9M | +5.6% |
| Net income | $757.5M | $984.6M | $1.23B | $2.26B | $1.33B | +15.2% |
| EPS (diluted) | $4.81 | $6.29 | $7.92 | $14.51 | $8.04 | +13.7% |
| EBITDA | $1.01B | $1.33B | $1.56B | $1.85B | $2.50B | +25.4% |
| R&D | $1.50B | $1.59B | $1.85B | $2.08B | $2.48B | +13.3% |
| SG&A | $323.0M | $313.6M | $376.7M | $568.5M | $769.6M | +24.2% |
Recent company headlines from major financial publishers.
The modal base case reflects steady execution of the core EDA duopoly and successful baseline integration of Ansys. Revenue expands from $7.05B in FY2025 to $9.72B in FY2026 (including $2.98B from Ansys), and reaches $11.03B in FY2027. Normalized operating margin expands steadily from 25.5% in FY2026 to 32.5% by FY2030. Discounted at a 10.12% cost of equity and 9.82% WACC, the synthesized fair value midpoint is $382.30.
In the upside scenario, explosive customer adoption of agentic AI engineering workflows and doubling of die-to-die chiplet IP design wins drive accelerated top-line expansion. Joint solutions with Ansys deliver faster-than-expected cross-selling synergies in 3DIC advanced packaging, while rapid deleveraging lowers the cost of capital. Five-year EPS growth averages 21.0%, supporting the upper boundary of our valuation framework.
| Ke ↓ / g → | 2.5% | 3.0% | 3.5% | 4.0% | 4.5% |
|---|---|---|---|---|---|
| 9.1% | $397 | $407 | $420 | $434 | $452 |
| 9.6% | $381 | $390 | $400 | $412 | $426 |
| 10.1% | $366 | $374 | $382 | $392 | $404 |
| 10.6% | $353 | $360 | $367 | $375 | $385 |
| 11.1% | $341 | $347 | $353 | $360 | $368 |
Upcoming earnings date and setup when available.
The rating each month's published research edition carried. A rating compares the price at analysis with the Fair value; it is not a record of whether the call was right.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |
